Avita Medical Inc
Research Avita Medical Inc (AVH) on Bullrun: market cap AUD 338.65M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVH
- ExchangeAU
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 338.65M
- Financial periodQ1 2026
- RevenueUSD 19.25M
- Net income-USD 10.61M
- Free cash flow-USD 10.09M
- Gross margin81.7%
Valuation Snapshot
latest market cap is AUD 338.65M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 71.61M | -USD 48.59M | -USD 32.93M | 82.1% | -0.35 | USD 10.24M | USD 46.05M | -USD 16.65M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-17 | AUD 338.65M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Avita Medical Inc's market cap?
Avita Medical Inc's market capitalization is AUD 338.65M.
What does Avita Medical Inc do?
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.